Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1

Nanotechnology-derived platforms, such as dendrimers, are very attractive in several biological applications. In the case of human immunodeficiency virus (HIV) infection, polyanionic carbosilane dendrimers have shown great potential as antiviral agents in the development of novel microbicides to prevent the sexual transmission of HIV-1. In this work, we studied the mechanism of two sulfated and naphthylsulfonated functionalized carbosilane dendrimers, G3-S16 and G2-NF16. They are able to inhibit viral infection at fusion and thus at the entry step. Both compounds impede the binding of viral particles to target cell surface and membrane fusion through the blockage of gp120–CD4 interaction. In addition, and for the first time, we demonstrate that dendrimers can inhibit cell-to-cell HIV transmission and difficult infectious synapse formation. Thus, carbosilane dendrimers’ mode of action is a multifactorial process targeting several proteins from viral envelope and from host cells that could block HIV infection at different stages during the first step of infection.

[1]  B. Clotet,et al.  Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells , 2009, AIDS.

[2]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born , 2012, Journal of chemical theory and computation.

[3]  L. Pérez-Alvárez,et al.  Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission , 2013, AIDS.

[4]  K. Morrow,et al.  Development of topical microbicides to prevent the sexual transmission of HIV. , 2010, Antiviral research.

[5]  Ramu Anandakrishnan,et al.  H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations , 2012, Nucleic Acids Res..

[6]  C. Coleman,et al.  Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells. , 2013, Advances in experimental medicine and biology.

[7]  V. KewalRamani,et al.  Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. , 2004, Virology.

[8]  Jenn-Huei Lii,et al.  The MM3 force field for amides, polypeptides and proteins , 1991 .

[9]  P. Ortega,et al.  Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[11]  M. Leal,et al.  Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[12]  Lynn Morris,et al.  Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.

[13]  S. Karim,et al.  Microbicides & their implications in HIV prevention , 2010, The Indian journal of medical research.

[14]  D. Schols,et al.  HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship. , 2012, Journal of medicinal chemistry.

[15]  S. Wesselingh,et al.  Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity , 2010, PloS one.

[16]  E. Arts,et al.  Past, present, and future of entry inhibitors as HIV microbicides. , 2012, Current HIV research.

[17]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  The infectious synapse formed between mature dendritic cells and CD4+ T cells is independent of the presence of the HIV-1 envelope glycoprotein , 2013, Retrovirology.

[19]  M. Leal,et al.  Dendrimers as topical microbicides with activity against HIV , 2012 .

[20]  F. Krebs,et al.  The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. , 2011, Antiviral research.

[21]  M. Malý,et al.  Synthesis, structure and molecular modelling of anionic carbosilane dendrimers. , 2012, Dalton transactions.

[22]  G. Towers,et al.  Identification of an Arsenic-Sensitive Block to Primate Lentiviral Infection of Human Dendritic Cells , 2007, Journal of Virology.

[23]  Raquel Lorente,et al.  The Spanish HIV BioBank: a model of cooperative HIV research , 2009, Retrovirology.

[24]  M. Bryszewska,et al.  Dendrimers: properties and applications. , 2001, Acta biochimica Polonica.

[25]  H. Gendelman,et al.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus , 1986, The Journal of experimental medicine.

[26]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[27]  T. Geijtenbeek,et al.  Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells. , 2013, International immunology.

[28]  Kwang S. Kim,et al.  Theory and applications of computational chemistry : the first forty years , 2005 .

[29]  F. Krebs,et al.  Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. , 2010, Virology.

[30]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[31]  A. Telenti,et al.  Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.

[32]  L. Collinson,et al.  HIV‐1 Trafficking to the Dendritic Cell–T‐Cell Infectious Synapse Uses a Pathway of Tetraspanin Sorting to the Immunological Synapse , 2005, Traffic.

[33]  L. Rohan,et al.  Progress in antiretroviral drug delivery using nanotechnology , 2010, International journal of nanomedicine.

[34]  S. Álvarez,et al.  Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Michel Alary,et al.  Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. , 2008, The New England journal of medicine.

[36]  C. Charpentier,et al.  Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide. , 2011, Future microbiology.

[37]  P. Ortega,et al.  Amine and ammonium functionalization of chloromethylsilane-ended dendrimers. Antimicrobial activity studies. , 2008, Organic & biomolecular chemistry.

[38]  M. Leal,et al.  Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro , 2013, AIDS.

[39]  R. Gómez,et al.  Synthesis of anionic carbosilane dendrimers via “click chemistry” and their antiviral properties against HIV , 2014 .

[40]  Morgan A Reuter,et al.  HIV Traffics through a Specialized, Surface-Accessible Intracellular Compartment during trans-Infection of T Cells by Mature Dendritic Cells , 2008, PLoS pathogens.

[41]  F. J. de la Mata,et al.  Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization. , 2012, Current medicinal chemistry.

[42]  P. Anton.  Future prospects and perspectives on microbicides. , 2012, Current HIV research.

[43]  P. Gorry,et al.  Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. , 2011, Antiviral research.

[44]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[45]  E. De Clercq,et al.  Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. , 2000, Molecular pharmacology.

[46]  D. Bernstein,et al.  Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection , 2000, Antimicrobial Agents and Chemotherapy.

[47]  T. Agatsuma,et al.  Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue. , 1994, Nucleic acids research.

[48]  Bette Korber,et al.  Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.

[49]  P. Ortega,et al.  Hyperbranched polymers versus dendrimers containing a carbosilane framework and terminal ammonium groups as antimicrobial agents. , 2011, Organic & biomolecular chemistry.